Nektar Therapeutics
NKTR
#4684
Rank
โ‚น186.44 B
Marketcap
โ‚น6,499
Share price
-3.25%
Change (1 day)
529.06%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2025 (TTM): -โ‚น13.57 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น55.23 Million. a decrease over its 2024 earnings that were of -โ‚น11.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น14.72 Billion30.44%
2024 -โ‚น11.29 Billion-56.85%
2023 -โ‚น26.15 Billion-24.31%
2022 -โ‚น34.55 Billion-30.25%
2021 -โ‚น49.54 Billion17.87%
2020 -โ‚น42.03 Billion0.88%
2019 -โ‚น41.66 Billion-164.46%
2018 โ‚น64.62 B-810.61%
2017 -โ‚น9.1 Billion-37.06%
2016 -โ‚น14.45 Billion89.22%
2015 -โ‚น7.64 Billion48.22%
2014 -โ‚น5.16 Billion-65.93%
2013 -โ‚น15.13 Billion-6.81%
2012 -โ‚น16.23 Billion28.95%
2011 -โ‚น12.59 Billion258.8%
2010 -โ‚น3.51 Billion-63.94%
2009 -โ‚น9.73 Billion-392.45%
2008 โ‚น3.32 B-211.74%
2007 -โ‚น2.98 Billion-79.57%
2006 -โ‚น14.58 Billion-16.9%
2005 -โ‚น17.54 Billion81.53%
2004 -โ‚น9.66 Billion54.19%
2003 -โ‚น6.27 Billion-33.87%
2002 -โ‚น9.48 Billion-9.6%
2001 -โ‚น10.48 Billion73.39%
2000 -โ‚น6.05 Billion108.9%
1999 -โ‚น2.9 Billion39.48%
1998 -โ‚น2.08 Billion60.02%
1997 -โ‚น1.3 Billion18.05%
1996 -โ‚น1.1 Billion31.82%
1995 -โ‚น0.84 Billion57.14%
1994 -โ‚น0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.175 T-21,678.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น964.73 B-6,654.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น849.63 B-5,872.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น47.81 Billion 224.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.122 T-14,521.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.335 T-9,173.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น95.6 M-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น28.74 B-295.34%๐Ÿ‡ฎ๐Ÿ‡ช Ireland